Three distinct H-2Ks molecules differing at the carboxy terminus are expressed on a tumor from SJL/J mice

J Immunol. 1986 Nov 1;137(9):3006-12.

Abstract

A dimethylbenzanthracene-induced leukemia of H-2s origin expressed at least two class I molecules on the cell surface that were precipitated by anti-H-2.19, an alloantiserum prepared against the private H-2Ks specificity. Mapping studies in recombinant inbred strains along with comparisons of tryptic peptide maps and N-terminal sequences indicated that the proteins were virtually identical and probably encoded by the same class I gene. When cells were labeled in the presence of tunicamycin, the proteins precipitated by anti-H-2.19 were further resolved into three distinct peptides. Experiments were performed to determine which of these various proteins were phosphorylated and which were recognized by an anti-synthetic peptide serum directed against the ultimate C-terminus of H-2K class I molecules. The results indicate that a single class I gene from the H-2Ks region may encode three class I molecules that differ only at the C-terminus due to alternative splicing of pre-mRNA.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Gene Expression Regulation
  • Glycosylation
  • H-2 Antigens / genetics*
  • Lymphoma, Non-Hodgkin / genetics
  • Lymphoma, Non-Hodgkin / immunology*
  • Mice
  • Mice, Inbred Strains
  • Molecular Weight
  • Peptide Fragments / analysis
  • Phosphoserine / metabolism
  • RNA Splicing
  • RNA, Messenger / genetics
  • Tunicamycin / pharmacology

Substances

  • H-2 Antigens
  • Peptide Fragments
  • RNA, Messenger
  • Tunicamycin
  • Phosphoserine